CINEMARK HOLDINGS INC (CNK)

US17243V1026 - Common Stock

32.25  -0.54 (-1.65%)

After market: 32.95 +0.7 (+2.17%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CNK. CNK was compared to 72 industry peers in the Entertainment industry. CNK has a medium profitability rating, but doesn't score so well on its financial health evaluation. CNK may be a bit undervalued, certainly considering the very reasonable score on growth



5

1. Profitability

1.1 Basic Checks

In the past year CNK was profitable.
CNK had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CNK reported negative net income in multiple years.
Of the past 5 years CNK 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 4.78%, CNK is in the better half of the industry, outperforming 77.46% of the companies in the same industry.
With an excellent Return On Equity value of 42.23%, CNK belongs to the best of the industry, outperforming 95.77% of the companies in the same industry.
CNK's Return On Invested Capital of 6.68% is fine compared to the rest of the industry. CNK outperforms 77.46% of its industry peers.
Industry RankSector Rank
ROA 4.78%
ROE 42.23%
ROIC 6.68%
ROA(3y)-3.23%
ROA(5y)-3.49%
ROE(3y)-104.01%
ROE(5y)-75.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of CNK (8.20%) is better than 81.69% of its industry peers.
CNK's Profit Margin has declined in the last couple of years.
CNK has a Operating Margin of 10.15%. This is in the better half of the industry: CNK outperforms 76.06% of its industry peers.
CNK's Operating Margin has declined in the last couple of years.
CNK has a Gross Margin of 64.89%. This is in the better half of the industry: CNK outperforms 77.46% of its industry peers.
CNK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.15%
PM (TTM) 8.2%
GM 64.89%
OM growth 3YN/A
OM growth 5Y-3.2%
PM growth 3YN/A
PM growth 5Y-1.8%
GM growth 3Y-0.58%
GM growth 5Y0.38%

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CNK is destroying value.
CNK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CNK has been increased compared to 5 years ago.
The debt/assets ratio for CNK has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.26, we must say that CNK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.26, CNK is in line with its industry, outperforming 56.34% of the companies in the same industry.
CNK has a debt to FCF ratio of 10.72. This is a negative value and a sign of low solvency as CNK would need 10.72 years to pay back of all of its debts.
CNK's Debt to FCF ratio of 10.72 is fine compared to the rest of the industry. CNK outperforms 61.97% of its industry peers.
CNK has a Debt/Equity ratio of 3.52. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.52, CNK is doing worse than 76.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.52
Debt/FCF 10.72
Altman-Z 1.26
ROIC/WACC0.89
WACC7.53%

2.3 Liquidity

A Current Ratio of 0.98 indicates that CNK may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.98, CNK is in line with its industry, outperforming 49.30% of the companies in the same industry.
A Quick Ratio of 0.96 indicates that CNK may have some problems paying its short term obligations.
With a Quick ratio value of 0.96, CNK perfoms like the industry average, outperforming 46.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.96

4

3. Growth

3.1 Past

CNK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 176.79%, which is quite impressive.
The Earnings Per Share has been decreasing by -8.99% on average over the past years.
CNK shows a decrease in Revenue. In the last year, the revenue decreased by -5.07%.
The Revenue has been decreasing by -0.98% on average over the past years.
EPS 1Y (TTM)176.79%
EPS 3YN/A
EPS 5Y-8.99%
EPS Q2Q%95.08%
Revenue 1Y (TTM)-5.07%
Revenue growth 3Y64.71%
Revenue growth 5Y-0.98%
Sales Q2Q%5.37%

3.2 Future

The Earnings Per Share is expected to grow by 0.65% on average over the next years.
Based on estimates for the next years, CNK will show a small growth in Revenue. The Revenue will grow by 1.80% on average per year.
EPS Next Y49.58%
EPS Next 2Y25.86%
EPS Next 3Y23.33%
EPS Next 5Y0.65%
Revenue Next Year-1.1%
Revenue Next 2Y4.76%
Revenue Next 3Y4.96%
Revenue Next 5Y1.8%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.81, CNK is valued on the expensive side.
CNK's Price/Earnings ratio is rather cheap when compared to the industry. CNK is cheaper than 80.28% of the companies in the same industry.
CNK's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.96.
A Price/Forward Earnings ratio of 16.55 indicates a correct valuation of CNK.
81.69% of the companies in the same industry are more expensive than CNK, based on the Price/Forward Earnings ratio.
CNK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.81
Fwd PE 16.55

4.2 Price Multiples

74.65% of the companies in the same industry are more expensive than CNK, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNK indicates a rather cheap valuation: CNK is cheaper than 85.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.3
EV/EBITDA 11.28

4.3 Compensation for Growth

CNK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CNK's earnings are expected to grow with 23.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y25.86%
EPS Next 3Y23.33%

0

5. Dividend

5.1 Amount

CNK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CINEMARK HOLDINGS INC

NYSE:CNK (11/21/2024, 8:20:21 PM)

After market: 32.95 +0.7 (+2.17%)

32.25

-0.54 (-1.65%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.95B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 20.81
Fwd PE 16.55
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.78%
ROE 42.23%
ROCE
ROIC
ROICexc
ROICexgc
OM 10.15%
PM (TTM) 8.2%
GM 64.89%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 3.52
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.98
Quick Ratio 0.96
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)176.79%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y49.58%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-5.07%
Revenue growth 3Y64.71%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y